Page last updated: 2024-11-04

acetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acetimidic acid : A carboximidic acid that is acetic acid in which the carbonyl oxygen is replaced by an imino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID178
CHEMBL ID16081
CHEBI ID27856
CHEBI ID49028
MeSH IDM0096876

Synonyms (110)

Synonym
BIDD:ER0566
essigsaeureamid
ethanamid
acetamid
ch3conh2
CHEBI:27856 ,
acetic acid amide
acetimidic acid
nsc-25945
nci-c02108
ethanamide
wln: zv1
nsc25945
methanecarboxamide
EU-0100003
acetamide, ~99% (gc)
NCGC00015030-01
lopac-a-0500
LOPAC0_000003
inchi=1/c2h5no/c1-2(3)4/h1h3,(h2,3,4
ai3-02060
acetamide (6ci,7ci,8ci,9ci)
amide c2
ethanimidic acid
caswell no. 003h
hsdb 4006
ccris 2
CHEBI:49028
brn 1071207
nsc 25945
amid kyseliny octove [czech]
acetimidic acid (van)
einecs 200-473-5
ACETAMIDE ,
C06244
60-35-5
DB02736
acetamide, zone-refined, purified by sublimation, 99%
NCGC00093530-01
NCGC00093530-02
NCGC00015030-02
A 0500
A0007
NCGC00015030-04
AKOS000118788
CHEMBL16081
smr000326670
MLS002153504
A832706
HMS3260A07
BMSE000895
amid kyseliny octove
unii-8xoe1jso29
8xoe1jso29 ,
ec 200-473-5
4-02-00-00399 (beilstein handbook reference)
BMSE000825
dtxcid505
cas-60-35-5
tox21_300776
dtxsid7020005 ,
NCGC00254680-01
02u ,
CCG-204099
acetoamide
AKOS015917387
NCGC00015030-05
NCGC00015030-03
STL283915
FT-0625737
FT-0621725
FT-0603458
FT-0621721
LP00003
acetamide [fhfi]
acetamide [who-dd]
acetamide [mi]
acetamide [iarc]
fema no. 4251
acetamide [hsdb]
S6011
gtpl4661
tox21_500003
NCGC00260688-01
STR01066
mfcd00008023
n-methylformamde
J-523678
F1908-0077
acetamide, analytical standard
acetamide, sublimed, 99%
acetamide, >=98.0% (gc)
acetamide, crystalline, >=99%
acetamide, >=99.0% (gc)
acetamide, >=98%
sr-01000076247
SR-01000076247-1
imidoacetic acid
acetylamine
BCP26153
acetic acid amide;ethanamide
Q421721
benzeneacetic?acid,?|a-amino-4-methyl-
SDCCGSBI-0049992.P002
NCGC00015030-06
CS-0015934
HY-Y0946
74330-92-0
EN300-15608
Z33546370

Research Excerpts

Overview

Acetamide is a common genotoxic byproduct found in synthetic routes of many APIs, mainly due to acetonitrile hydrolysis. selective scavenging is a still a challenging task.

ExcerptReferenceRelevance
"Acetamide is a common genotoxic byproduct found in synthetic routes of many APIs, mainly due to acetonitrile hydrolysis, and selective scavenging is a still a challenging task."( Intrinsic acetamide brush-off by polyurea biodendrimers.
Bonifácio, VDB; Martinho, N; Pires, RF; Zloh, M, 2021
)
1.75

Effects

ExcerptReferenceRelevance
"Acetamide has been classified as a possible human carcinogen, but uncertainties exist about its levels in foods. "( Exposure Assessment of Acetamide in Milk, Beef, and Coffee Using Xanthydrol Derivatization and Gas Chromatography/Mass Spectrometry.
Bals, B; Bringi, V; Campbell, T; Haddad, D; Jones, AD; Julian, A; Moore, J; Nielson, C; Teymouri, F; Vismeh, R, 2018
)
2.23

Toxicity

ExcerptReferenceRelevance
" These mutations are believed to result in a "gain of toxic function", leading to neuronal degeneration."( Disulfide scrambling in superoxide dismutase 1 reduces its cytotoxic effect in cultured cells and promotes protein aggregation.
Johansson, AS; Leinartaitė, L, 2013
)
0.39
" These data, for the first time, provide a comprehensive view for the toxic effects of monoHAcAms."( Mice in vivo toxicity studies for monohaloacetamides emerging disinfection byproducts based on metabolomic methods.
Deng, Y; Ding, L; Ren, H; Wu, B; Xu, K; Zhang, R; Zhang, Y, 2014
)
0.67
" Intraperitoneal or po administration of the new chemical entities (NCEs), 3b and 3r, in concentrations equal to a toxic dose of ApAP did not result in the formation of NAPQI."( A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis.
Abet, V; Alvarez-Builla, J; Bazan, HA; Bazan, NG; Bhattacharjee, S; Burgos, C; Edwards, S; Gordon, WC; Heap, J; Jun, B; Ledet, AJ; Pahng, AR; Paul, D; Recio, J, 2020
)
0.8

Pharmacokinetics

ExcerptReferenceRelevance
" Parameter estimates from 14CO2 concentrations in breath as a function of time data closely correspond to the pharmacokinetic parameters of AHA in patients indicating that CO2 may be a primary metabolite derived directly from AHA rather than a secondary metabolite formed by the metabolism of an intermediate product."( Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi.
Feldman, S; Griffith, DP; Putcha, L, 1985
)
0.27

Dosage Studied

ExcerptRelevanceReference
"5-5 g/kg of acetamide was dosed to sheep at various intervals before and sometimes after the administration of 5 g/kg of gifblaar, 1 out of 5 survived, compared with 0 out of 2 controls."( The efficacy of acetamide for the treatment of experimental Dichapetalum cymosum (gifblaar) poisoning in sheep.
Egyed, MN; Schultz, RA, 1986
)
1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
carboximidic acid
acetamidesCompounds with the general formula RNHC(=O)CH3.
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
N-acylammoniaA carboxamide obtained by the formal condensation of the carboxy group of any carboxylic acid with ammonia.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
tetramethylpyrazine degradation514

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
15-lipoxygenase, partialHomo sapiens (human)Potency0.00790.012610.691788.5700AID887
regulator of G-protein signaling 4Homo sapiens (human)Potency1.49890.531815.435837.6858AID504845
estrogen nuclear receptor alphaHomo sapiens (human)Potency145.00400.000229.305416,493.5996AID743069
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency4.15680.035520.977089.1251AID504332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency0.00110.540617.639296.1227AID2364; AID2528
peripheral myelin protein 22 isoform 1Homo sapiens (human)Potency9.528323.934123.934123.9341AID1967
flap endonuclease 1Homo sapiens (human)Potency37.68580.133725.412989.1251AID588795
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency4.25620.425612.059128.1838AID504536
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency0.00560.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (30)

Assay IDTitleYearJournalArticle
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID23734Micelle/water partition coefficient (Pmic) of the compound was determined1996Journal of medicinal chemistry, Jun-21, Volume: 39, Issue:13
Thermodynamic aspects of hydrophobicity and the blood-brain barrier permeability studied with a gel filtration chromatography.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID674462Dissociation constant, pKa of the compound in DMSO at 25 degC2012Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
RCAI-84, 91, and 105-108, ureido and thioureido analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (372)

TimeframeStudies, This Drug (%)All Drugs %
pre-199055 (14.78)18.7374
1990's34 (9.14)18.2507
2000's103 (27.69)29.6817
2010's132 (35.48)24.3611
2020's48 (12.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 77.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index77.31 (24.57)
Research Supply Index5.97 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index135.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (77.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.26%)5.53%
Reviews5 (1.29%)6.00%
Case Studies1 (0.26%)4.05%
Observational0 (0.00%)0.25%
Other381 (98.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]